Bachem Holding Overview

  • Founded
  • 1971
Founded
  • Status
  • Public
  • Employees
  • 1,695
Employees
  • Stock Symbol
  • BANB
Stock Symbol
  • Investments
  • 4
  • Share Price
  • $73.30
  • (As of Friday Closing)

Bachem Holding General Information

Description

Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients, as well as on the development of biochemical products for research purposes. The group markets its product under the Bachem and Clinalfa brands. The business of the firm can be seen booming across the market of Switzerland, USA, Austria, Great Britain, Germany and internationally and it generates revenue through the sale of the product.

Contact Information

Website
www.bachem.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Stock Exchange
SWX
Primary Office
  • Hauptstrasse 144
  • 4416 Bubendorf
  • Switzerland
+41 058 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bachem Holding Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$73.30 $71.03 $67.36 - $925.69 $5.4B 73.7M 115K $1.77

Bachem Holding Financials Summary

In Thousands,
USD
TTM 31-Dec-2021 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 11,099,750 11,099,750 6,379,772 2,275,287
Revenue 550,440 550,440 428,105 315,701
EBITDA 175,193 175,193 124,860 86,116
Net Income 125,440 125,440 83,132 54,507
Total Assets 1,420,519 1,420,519 813,666 667,896
Total Debt 22,824 22,824 123,101 110,535
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bachem Holding Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bachem Holding‘s full profile, request access.

Request a free trial

Bachem Holding Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It f
Biotechnology
Bubendorf, Switzerland
1,695 As of 2021
00000
00000000 00000

00000000

sse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in
0000 000000000
Piscataway, NJ
0000 As of 0000
00000
0.000 0000-00-00
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bachem Holding Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000000000 Private Equity-Backed Piscataway, NJ 0000 00000 000000000 00000
You’re viewing 1 of 1 competitors. Get the full list »

Bachem Holding Patents

Bachem Holding Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2021512157-A Production of glucagon peptide Pending 30-Jan-2018 0000000000
EP-3746466-A1 Manufacture of glucagon peptides Pending 30-Jan-2018 00000000
EP-3517543-B1 Manufacture of glucagon peptides Active 30-Jan-2018 00000000
EP-3517543-A1 Manufacture of glucagon peptides Granted 30-Jan-2018 0000000000 0
US-20210122782-A1 Manufacture of glucagon peptides Pending 30-Jan-2018 C07K14/605
To view Bachem Holding’s complete patent history, request access »

Bachem Holding Executive Team (10)

Name Title Board Seat Contact Info
Thomas Meier Chief Executive Officer
Alain Schaffter Chief Financial Officer
Anne-Kathrin Stoller Chief Operating Officer Bachem Americas
Roland Schürmann Chief Operating Officer & Member of the Corporate Executive Committee
Torsten Wöhr Ph.D Chief Marketing Officer
You’re viewing 5 of 10 executive team members. Get the full list »

Bachem Holding Board Members (5)

Name Representing Role Since
00000 000000000 Bachem Holding Board Member 000 0000
000000 000000 Bachem Holding Board Member & Vice Chairman 000 0000
0000000 0000 00.0 Self Board Member 000 0000
000000 00ü0 00.0 Bachem Holding Board Member 000 0000
You’re viewing 4 of 5 board members. Get the full list »

Bachem Holding Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bachem Holding Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000 27-Mar-2015 0000000000 000.00 Other Pharmaceuticals and Biotechnology 000000 00
000000 000000 13-Aug-2007 00000 0000 000.00 Biotechnology
00000 0000000 01-Jul-2007 000000000 00.000 Buildings and Property 0000000 0
Pevion Biotech 15-Jan-2002 Joint Venture 00.000 Biotechnology
To view Bachem Holding’s complete investments and acquisitions history, request access »

Bachem Holding Subsidiaries (1)

Company Name Industry Location Founded
00000000 0000000 Other Pharmaceuticals and Biotechnology Sunnyvale, CA 0000
To view Bachem Holding’s complete subsidiaries history, request access »

Bachem Holding Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 0000000 13-Aug-2007 00000 00000 00 000.00 Completed
  • 4 buyers
Pevion Biotech 15-Jan-2002 Joint Venture 00.000 Completed
  • 2 buyers
To view Bachem Holding’s complete exits history, request access »